Q2 2025 Earnings Call Transcript February 5, 2025 Accuray Incorporated beats earnings expectations. Reported EPS is $0.02, ...

She also was a teaching assistant in the Gabelli School’s Ground Floor course for first-year business students, a freshman advisor, and a member of Fordham’s women’s club soccer team throughout her ...

Kim Kelderman; Chief Executive Officer, Chief Operating Officer, Director; Bio-Techne Corp James Hippel; Chief Financial Officer, Executive Vice President - Finance; Bio-Techne Corp Good morning, and ...

U.S. Big 4 Had A Strong 2024, As Delta Surpassed $60B Revenue Mark is published in Aviation Daily, an Aviation Week ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

Bristol-Myers Squibb (BMY) to announce Q4 earnings on February 6th. Analysts expect $1.47 EPS on $11.56B revenue.

Bio-Techne Corp (NASDAQ:TECH) reported stronger-than-expected earnings for the second quarter of fiscal year 2024, with adjusted earnings per share (EPS) of $0.42, surpassing the forecasted $0.39.